BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28668410)

  • 1. Focal lesions in cirrhosis: Not always HCC.
    Ronot M; Dioguardi Burgio M; Purcell Y; Pommier R; Brancatelli G; Vilgrain V
    Eur J Radiol; 2017 Aug; 93():157-168. PubMed ID: 28668410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?
    Galia M; Taibbi A; Marin D; Furlan A; Dioguardi Burgio M; Agnello F; Cabibbo G; Van Beers BE; Bartolotta TV; Midiri M; Lagalla R; Brancatelli G
    Diagn Interv Radiol; 2014; 20(3):222-8. PubMed ID: 24509186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indications for liver biopsy in liver tumors].
    Stölzel U; Tannapfel A; Wittekind C; Hamm B; Schuppan D
    Dtsch Med Wochenschr; 2000 Sep; 125(36):1041-4. PubMed ID: 11022600
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
    Shetty AS; Fowler KJ; Brunt EM; Agarwal S; Narra VR; Menias CO
    Abdom Imaging; 2014 Apr; 39(2):310-22. PubMed ID: 24407728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
    Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
    Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis.
    Chen ZG; Xu L; Zhang SW; Huang Y; Pan RH
    World J Gastroenterol; 2015 Feb; 21(5):1621-7. PubMed ID: 25663782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.
    Xu J; Igarashi S; Sasaki M; Matsubara T; Yoneda N; Kozaka K; Ikeda H; Kim J; Yu E; Matsui O; Nakanuma Y
    Liver Int; 2012 Aug; 32(7):1156-64. PubMed ID: 22417172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma.
    Jain R; Malhotra V; Kumar N; Sarin SK
    Trop Gastroenterol; 1998; 19(3):100-1. PubMed ID: 9828706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of intrahepatic cholangiocarcinoma in cirrhotic patients scanned by gadobenate dimeglumine-enhanced magnetic resonance imaging: diagnostic accuracy and confidence.
    Quaia E; Angileri R; Arban F; Gennari AG; Cova MA
    Clin Imaging; 2015; 39(6):1032-8. PubMed ID: 26278014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
    Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
    Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
    Hwang J; Kim YK; Park MJ; Lee MH; Kim SH; Lee WJ; Rhim HC
    J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign focal liver lesions masquerading as primary liver cancers on MRI.
    Subramanian M; Low HM; Kim MJ; Tan CH
    Diagn Interv Radiol; 2020 May; 26(3):168-175. PubMed ID: 32229432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ins and outs of liver imaging.
    O'Neill EK; Cogley JR; Miller FH
    Clin Liver Dis; 2015 Feb; 19(1):99-121. PubMed ID: 25454299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.
    Sheng RF; Xie YH; Ji Y; Chen CZ; Yang L; Jin KP; Zeng MS
    Abdom Radiol (NY); 2016 Nov; 41(11):2102-2114. PubMed ID: 27315077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perihilar cholangiocarcinoma arising in hepatitis C virus-related liver cirrhosis with hepatocellular carcinoma.
    Fujii T; Zen Y; Nakanuma Y
    J Gastroenterol; 2007 Aug; 42(8):698-702. PubMed ID: 17701135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
    Teefey SA; Hildeboldt CC; Dehdashti F; Siegel BA; Peters MG; Heiken JP; Brown JJ; McFarland EG; Middleton WD; Balfe DM; Ritter JH
    Radiology; 2003 Feb; 226(2):533-42. PubMed ID: 12563151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls of cirrhosis-related nodules.
    Jeong YY; Yim NY; Kang HK
    AJR Am J Roentgenol; 2005 Oct; 185(4):1024-32. PubMed ID: 16177427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal nodular hyperplasia-like lesion in a cirrhotic liver mimicking a cholangiocarcinoma.
    Loh JT; Chea YW; Lim KH; Wan WK; Wong JS
    J Clin Pathol; 2014 Apr; 67(4):377-80. PubMed ID: 24357439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.